T L Croston1, A P Nayak2, A R Lemons2, W T Goldsmith3, J K Gu4, D R Germolec5, D H Beezhold6, B J Green2. 1. Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Morgantown, WV, USA. xzu9@cdc.gov. 2. Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Morgantown, WV, USA. 3. Engineering and Control Technology Branch, Health Effects Laboratory Division, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Morgantown, WV, USA. 4. Biostatistics and Epidemiology Branch, Health Effects Laboratory Division, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Morgantown, WV, USA. 5. Toxicology Branch, DNTP/NIEHS, Research Triangle Park, NC, USA. 6. Office of the Director, Health Effects Laboratory Division, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Morgantown, WV, USA.
Abstract
BACKGROUND: Personal exposure to fungal bioaerosols derived from contaminated building materials or agricultural commodities may induce or exacerbate a variety of adverse health effects. The genomic mechanisms that underlie pulmonary immune responses to fungal bioaerosols have remained unclear. OBJECTIVE: The impact of fungal viability on the pulmonary microRNA and messenger RNA profiles that regulate murine immune responses was evaluated following subchronic inhalation exposure to Aspergillus fumigatus conidia. METHODS: Three groups of naïve B6C3F1/N mice were exposed via nose-only inhalation to A. fumigatus viable conidia, heat-inactivated conidia (HIC), or HEPA-filtered air twice a week for 13 weeks. Total RNA was isolated from whole lung 24 and 48 h postfinal exposure and was further processed for gene expression and microRNA array analysis. The molecular network pathways between viable and HIC groups were evaluated. RESULTS: Comparison of data sets revealed increased Il4, Il13 and Il33 expression in mice exposed to viable vs. HIC. Of 415 microRNAs detected, approximately 50% were altered in mice exposed to viable vs. HIC 48 h postexposure. Significantly down-regulated (P ≤ 0.05) miR-29a-3p was predicted to regulate TGF-β3 and Clec7a, genes involved in innate responses to viable A. fumigatus. Also significantly down-regulated (P ≤ 0.05), miR-23b-3p regulates genes involved in pulmonary IL-13 and IL-33 responses and SMAD2, downstream of TGF-β signalling. Using Ingenuity Pathway Analysis, a novel interaction was identified between viable conidia and SMAD2/3. CONCLUSIONS AND CLINICAL RELEVANCE: Examination of the pulmonary genetic profiles revealed differentially expressed genes and microRNAs following subchronic inhalation exposure to A. fumigatus. MicroRNAs regulating genes involved in the pulmonary immune responses were those with the greatest fold change. Specifically, germinating A. fumigatus conidia were associated with Clec7a and were predicted to interact with Il13 and Il33. Furthermore, altered microRNAs may serve as potential biomarkers to evaluate fungal exposure. Published 2016. This article is a U.S. Government work and is in the public domain in the USA.
BACKGROUND: Personal exposure to fungal bioaerosols derived from contaminated building materials or agricultural commodities may induce or exacerbate a variety of adverse health effects. The genomic mechanisms that underlie pulmonary immune responses to fungal bioaerosols have remained unclear. OBJECTIVE: The impact of fungal viability on the pulmonary microRNA and messenger RNA profiles that regulate murine immune responses was evaluated following subchronic inhalation exposure to Aspergillus fumigatus conidia. METHODS: Three groups of naïve B6C3F1/N mice were exposed via nose-only inhalation to A. fumigatus viable conidia, heat-inactivated conidia (HIC), or HEPA-filtered air twice a week for 13 weeks. Total RNA was isolated from whole lung 24 and 48 h postfinal exposure and was further processed for gene expression and microRNA array analysis. The molecular network pathways between viable and HIC groups were evaluated. RESULTS: Comparison of data sets revealed increased Il4, Il13 and Il33 expression in mice exposed to viable vs. HIC. Of 415 microRNAs detected, approximately 50% were altered in mice exposed to viable vs. HIC 48 h postexposure. Significantly down-regulated (P ≤ 0.05) miR-29a-3p was predicted to regulate TGF-β3 and Clec7a, genes involved in innate responses to viable A. fumigatus. Also significantly down-regulated (P ≤ 0.05), miR-23b-3p regulates genes involved in pulmonary IL-13 and IL-33 responses and SMAD2, downstream of TGF-β signalling. Using Ingenuity Pathway Analysis, a novel interaction was identified between viable conidia and SMAD2/3. CONCLUSIONS AND CLINICAL RELEVANCE: Examination of the pulmonary genetic profiles revealed differentially expressed genes and microRNAs following subchronic inhalation exposure to A. fumigatus. MicroRNAs regulating genes involved in the pulmonary immune responses were those with the greatest fold change. Specifically, germinating A. fumigatus conidia were associated with Clec7a and were predicted to interact with Il13 and Il33. Furthermore, altered microRNAs may serve as potential biomarkers to evaluate fungal exposure. Published 2016. This article is a U.S. Government work and is in the public domain in the USA.
Entities:
Keywords:
allergens and epitopes; animal models; genetics
Authors: Mathias Oertli; Daniela B Engler; Esther Kohler; Manuel Koch; Thomas F Meyer; Anne Müller Journal: J Immunol Date: 2011-08-31 Impact factor: 5.422
Authors: Lina Fassi Fehri; Manuel Koch; Elena Belogolova; Hany Khalil; Christian Bolz; Behnam Kalali; Hans J Mollenkopf; Macarena Beigier-Bompadre; Alexander Karlas; Thomas Schneider; Yuri Churin; Markus Gerhard; Thomas F Meyer Journal: PLoS One Date: 2010-03-02 Impact factor: 3.240
Authors: Amanda D Buskirk; Brett J Green; Angela R Lemons; Ajay P Nayak; W Travis Goldsmith; Michael L Kashon; Stacey E Anderson; Justin M Hettick; Steven P Templeton; Dori R Germolec; Donald H Beezhold Journal: PLoS One Date: 2014-10-23 Impact factor: 3.240
Authors: Angela R Lemons; Tara L Croston; W Travis Goldsmith; Mark A Barnes; Mukhtar A Jaderson; Ju-Hyeong Park; Walter McKinney; Donald H Beezhold; Brett J Green Journal: Inhal Toxicol Date: 2019-12-24 Impact factor: 2.724
Authors: Tara L Croston; Angela R Lemons; Mark A Barnes; William T Goldsmith; Marlene S Orandle; Ajay P Nayak; Dori R Germolec; Brett J Green; Donald H Beezhold Journal: Am J Respir Cell Mol Biol Date: 2020-05 Impact factor: 6.914
Authors: Juliana S de Curcio; Juliano D Paccez; Evandro Novaes; Mathias Brock; Célia Maria de Almeida Soares Journal: Front Microbiol Date: 2018-12-11 Impact factor: 5.640
Authors: Sarah R Haines; Rachel I Adams; Brandon E Boor; Thomas A Bruton; John Downey; Andrea R Ferro; Elliott Gall; Brett J Green; Bridget Hegarty; Elliott Horner; David E Jacobs; Paul Lemieux; Pawel K Misztal; Glenn Morrison; Matthew Perzanowski; Tiina Reponen; Rachael E Rush; Troy Virgo; Celine Alkhayri; Ashleigh Bope; Samuel Cochran; Jennie Cox; Allie Donohue; Andrew A May; Nicholas Nastasi; Marcia Nishioka; Nicole Renninger; Yilin Tian; Christina Uebel-Niemeier; David Wilkinson; Tianren Wu; Jordan Zambrana; Karen C Dannemiller Journal: Build Environ Date: 2019-12-18 Impact factor: 6.456
Authors: Luis Caraballo; Rudolf Valenta; Leonardo Puerta; Anna Pomés; Josefina Zakzuk; Enrique Fernandez-Caldas; Nathalie Acevedo; Mario Sanchez-Borges; Ignacio Ansotegui; Luo Zhang; Marianne van Hage; Eva Fernández; Luisa Arruda; Susanne Vrtala; Mirela Curin; Hans Gronlund; Antonina Karsonova; Jonathan Kilimajer; Ksenja Riabova; Daria Trifonova; Alexander Karaulov Journal: World Allergy Organ J Date: 2020-04-29 Impact factor: 4.084